Sugar-binding sites with specificity for glucosamine in the guinea pig middle ear mucosa.
Glucosamine-binding sites were detected in Lowicryl K4M-embedded guinea pig middle ear mucosa by electron microscopy, using glucosaminyl bovine serum albumin. Incubation of ultrathin tissue sections with gold-labeled glucosaminyl bovine serum albumin (GlcN/BSA/gold) resulted in binding mainly on cilia, microvilli, rough endoplasmic reticulum and nuclei. The sugar binding was not inhibited after ultrathin sections had been digested with trypsin or neuraminidase. Various carbohydrates and glycoconjugates were tested as competitive inhibitors of GlcN/BSA/gold labeling on the tissue sections. The sugar specificity range detected by the glucosamine-binding sites included glucosamine, N-acetylglucosamine, mannose and fucose, whereas N-acetylgalactosamine, galactose and glucose were not detectable. A series of endotoxic substances such as Salmonella minnesota Re595 lipid A complex with BSA and lipopolysaccharides (LPS) derived from Escherichia coli 055:B5 or S. minnesota Re595 also competed with GlcN/BSA/gold binding. This indicates that the lipid A backbone glucosamine or other carbohydrate portions of LPS is a part of the structure recognized by glucosamine-binding sites.
Tanimura
F
F
Department of Otolaryngology, Municipal Yamashiro Hospital, Kyoto, Japan.
Morioka
H
H
Murakami
Y
Y
D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D002236:Carbohydrate Conformation; D004432:Ear, Middle / Q000378:metabolism* / Q000648:ultrastructure; D005944:Glucosamine / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism; D017979:Gold Colloid; D006168:Guinea Pigs; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D009092:Mucous Membrane / Q000378:metabolism / Q000648:ultrastructure; D012710:Serum Albumin, Bovine
D006023:Glycoproteins; D017979:Gold Colloid; D012710:Serum Albumin, Bovine; D005944:Glucosamine